Patents for C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom (69,397) |
---|
08/30/2007 | US20070203072 Hcv Ns-3 Serine Protease Inhibitors |
08/30/2007 | DE4245036B4 Flüssigkristalline Verbindungen Liquid-crystalline compounds |
08/30/2007 | CA2643983A1 Cinnoline derivatives as phosphodiesterase 10 inhibitors |
08/30/2007 | CA2643963A1 Cinnoline derivatives as phosphodiesterase 10 inhibitors |
08/30/2007 | CA2643272A1 Gent for treating or preventing digestive ulcer |
08/30/2007 | CA2642762A1 Pyrrolidine derivatives as erk inhibitors |
08/30/2007 | CA2642610A1 Amide derivative or salt thereof |
08/30/2007 | CA2637531A1 Compounds having 5-ht6 receptor affinity |
08/29/2007 | EP1824843A2 Inhibitors of protein kinases |
08/29/2007 | EP1824839A2 Substituted biaryl analogues |
08/29/2007 | EP1824831A2 Histone deacetylase inhibitors |
08/29/2007 | EP1824822A2 Novel 4-aminopiperidine derivatives as plasmepsin ii inhibitors |
08/29/2007 | EP1824486A1 Benzdioxane piperazine derivatives with a combination of affinity for dopamine-d2 receptors and serotonin reuptake sites |
08/29/2007 | EP1824338A1 3-cyclopropyl-4-(3-amino-2-methylbenzoyl)pyrazols and the use of the same as herbicides |
08/29/2007 | EP1725538B1 Pyridazinone ureas as antagonists of a4 integrins |
08/29/2007 | EP1351934B1 Naphthalene derivatives which bind to the ep4 receptor |
08/29/2007 | EP1268431B1 3-cyanoquinolines,3-cyano-1,6-naphthyridines, and 3-cyano-1,7-naphthyridines as protein kinase inhibitors |
08/29/2007 | EP1024814B1 Use of antifungal agents for the topical treatment of fungus-induced mucositis |
08/29/2007 | CN101027405A Process for synthesis of derivatives, compound library, method for making the mase, and screening method |
08/29/2007 | CN101027295A Chemical compounds and pharmaceutical compositions containing them for the treatment of inflammatory disorders |
08/29/2007 | CN101027294A Phenyl DIAZEPAN carboxamides and annelated phenyl piperazine carboxamides containing oxygen and used as dopamine D3 antagonists |
08/29/2007 | CN101027293A Photoreactive compound, photoreactive polyamine and method for producing polyamine sheet |
08/29/2007 | CN101027292A Compounds, compositions containing them, preparation thereof and uses thereof |
08/29/2007 | CN101027291A Benzimidazole derivatives and their use as cannabinoid receptor ligands |
08/29/2007 | CN101024627A Nitrogen-containing aromatic derivatives |
08/29/2007 | CN101024626A Intermediate synthesizing compound for preparing atorvastatin calcium |
08/29/2007 | CN100334083C Piperidine derivatives as CCR5 inhibitors |
08/29/2007 | CN100334077C Benzimidazole derivatives and their use as GNRH antagonists |
08/28/2007 | US7262295 Wear resistance coating containing photochromic compound and polymer |
08/28/2007 | US7262216 Benzofuran compounds and their use as antidepressants and anxiolytics |
08/28/2007 | US7262213 Administering (-)-(2S,4S)-1-(2-Hydroxymethyl-1,3-dioxolan-4-yl)cytosine (also referred to as (-)-OddC) for therapy of cancer such as non-small cell lung cancer, colon cancer, breast cancer, prostate cancer, ovarian cancer, leukemia, CNS cancer, melanoma, renal cancer, and lymphoma cancer |
08/28/2007 | US7262211 Activity as non-covalent inhibitors of urokinase and having activity in reducing or inhibiting blood vessel formation are provided. These compounds have at a group having a guanidino moiety or derivative thereof. These compounds are useful for |
08/28/2007 | US7262207 Antidiabetic agents; hyperglycemic agents; obesity; atherosclerosis; immunomodulatory agents |
08/28/2007 | US7262206 Having inhibiting effect on protein kinases, particularly an inhibiting effect on the activity of glycogen synthase kinase (GSK), for therapy of type II diabetes mellitus, diabetes associated disorders such as diabetic neuropathy, degenerative neurological diseases such as Alz-heimer's disease, stroke |
08/28/2007 | US7262201 Quinazoline derivatives |
08/28/2007 | CA2412152C Phenyl-substituted 5,6-dihydropyrone derivatives for use as pesticides and herbicides |
08/28/2007 | CA2265874C Condensed n-acylindoles as antitumor agents |
08/28/2007 | CA2210889C Bis-sulfonamide hydroxyethylamino retroviral protease inhibitors |
08/23/2007 | WO2007095561A2 Indole-3-carboxylic acid amide, ester, thioamide and thiol ester compounds bearing aryl or heteroaryl groups having sphingosine-1-phosphate (s1p) receptor antagonist biological activity |
08/23/2007 | WO2007094513A2 Cyclic amine compound and use thereof for the prophylaxis or treatment of hypertension |
08/23/2007 | WO2007093880A2 Novel pyrone-indole derivatives and process for their preparation |
08/23/2007 | WO2007093364A1 Azacyclyl-substituted aryldihydroisoquinolinones, process for their preparation and their use as medicaments |
08/23/2007 | WO2007071396A3 Pyrazinoylguanidine compounds useful in the treatment of inflammatory or allergic conditions |
08/23/2007 | WO2007061741A3 Modulators of the h3 receptor useful for the treatment of disorders related thereto |
08/23/2007 | WO2006076452A8 An exo-selective synthesis of himbacine analogs |
08/23/2007 | US20070197784 illumination or heating 2(R)-Benzoyloxymethyl-[1,3]dioxolane-4(R)-carboxylic acid in the presence of diacetoxy iodobenzene and iodine, to from Benzoic acid 4(R,S)-acetoxy-[1,3]dioxolan-2(R)-ylmethyl ester, used for modifying of purine or pyrimidine bases; antitumor or anticarcinogenic agents |
08/23/2007 | US20070197778 having two or more maleimide groups and is a fluorescent labeling agent capable of switching fluorescence on and off by a reaction with a thiol group or a peptide or protein containing a cysteine residue; to introduce fluorescent tag of small molecular size into target protein at high sensitivity |
08/23/2007 | US20070197631 Processes for preparing darifenacin hydrobromide |
08/23/2007 | US20070197630 Pure darifenacin hydrobromide substantially free of oxidized darifenacin and salts thereof and processes for the preparation thereof |
08/23/2007 | US20070197603 Substituted indole ligands for the orl-1 receptor |
08/23/2007 | US20070197600 Heterocyclic substituted 4-(aminomethyl)-piperidine benzamides as 5ht4-antagonists |
08/23/2007 | US20070197597 Process for the preparation of tryptase inhibitors |
08/23/2007 | US20070197587 Quinoline Derivatives as CRTH2 Antagonists |
08/23/2007 | US20070197547 4-(1-piperazinyl)-2(1H)-quinolone and 4-(1-piperazinyl)quinoline derivatives, e.g., 4-(1-piperazinyl)-1-methyl-3-nitro-2(1H)-quinolone |
08/23/2007 | US20070197542 hydroxy{(1S)-4-pyrimidin-2-yl-1-[({4-[5-(2,2,2-trifluoroethoxy)pyrimidin-2-yl]piperazin-1-yl}sulfonyl)methyl]butyl}formamide; collagenase 3 inhibitor; tissue remodelling such as embryonic development, bone formation and uterine remodelling during menstruation |
08/23/2007 | US20070197462 Administering 5-substituted uracil-nucleosides or its pharmaceutically acceptable salt or prodrug for therapy of infected with Epstein-Barr virus (EBV) or Kaposi's sarcoma-associated herpes (KHSV) |
08/23/2007 | US20070197450 Fused heterocycle derivative, medicinal composition containing the same, and medicinal use thereof |
08/23/2007 | US20070197391 Herbicidal pyrimidines |
08/23/2007 | CA2642668A1 Indole-3-carboxylic acid amide and ester compounds bearing phenyl groups having sphingosine-1-phosphate (sip) receptor antagonist biological activity |
08/23/2007 | CA2638787A1 Cyclic amine compound and use thereof for the prophylaxis or treatment of hypertension |
08/23/2007 | CA2636873A1 Azacyclyl-substituted aryldihydroisoquinolinones, process for their preparation and their use as medicaments |
08/22/2007 | EP1820798A1 7-membered ring compound, process for producing the same, and medicinal use thereof |
08/22/2007 | EP1820503A2 Aminoindazole derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions containing them |
08/22/2007 | EP1819690A2 Chroman compounds |
08/22/2007 | EP1819681A1 7-(2h-pyrazol-3-yl)-3,5-dihydroxy-heptanoic acid derivatives as hmg co-a reductase inhibitors for the treatment of lipidemia |
08/22/2007 | EP1819672A1 Indole-2-carboxylic acid amides |
08/22/2007 | EP1819341A2 Il-12 modulatory compounds |
08/22/2007 | EP1572670B1 5-substituted-pyrazine or -pyridine glucokinase activators |
08/22/2007 | EP1567502B1 Substituted dihydrophenanthridinesul fonamides |
08/22/2007 | EP1554246B1 Dihydropyridinone derivatives as hne inhibitors |
08/22/2007 | EP1448523B1 Heterocyclic compounds and methods of use |
08/22/2007 | EP1402024B1 Templated molecules and methods for using such molecules |
08/22/2007 | EP1359908B1 Quinolines and nitrogenated derivatives thereof substituted in 4-position by a piperidine-containing moiety and their use as antibacterial agents |
08/22/2007 | EP1300399B1 Phenylpyridazine derivatives and drugs containing the same |
08/22/2007 | EP1150980B1 16-halogen-epothilone derivatives, method for producing them and their pharmaceutical use |
08/22/2007 | EP1124824B1 Chromenone and chromanone derivatives as integrin inhibitors |
08/22/2007 | CN1332959C Heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonists |
08/22/2007 | CN1332952C 4-(substituted cycloalkylmethyl) imidazole-2-thiones, 4-(substituted cycloalkenylmethyl) imidazole-2-thiones, 4-(substituted cycloalkylmethyl) imidazol-2-ones and 4-(substituted cycloalkenylmethyl) im |
08/22/2007 | CN1332951C New process for the synthesis of 1,3-dihydro-2H-3-benzazepin-2-one compounds, and application in the synthesis of ivabradine and addition salts thereof with a pharmaceutically acceptable acid |
08/22/2007 | CN1332939C Novel compounds inhibiting factor Xa activity |
08/22/2007 | CN101023075A Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof |
08/22/2007 | CN101023073A Heteroaroyl-substituted serine amides utilized as herbicides |
08/22/2007 | CN101023072A Piperidinyl targeting compounds that selectively bind integrins |
08/22/2007 | CN101023071A New heterocyclic amides |
08/22/2007 | CN101023063A Azine-carboxamides as anti-cancer agent |
08/22/2007 | CN101022807A Process and intermediate compounds useful in the preparation of statins, particularly rosuvastatin |
08/21/2007 | US7259271 [4-(tert-butyldimethylsilanyloxy)-3-oxobutyl]methylcarbamic acid tert-butyl ester; (R)-6,8-difluoro-3,4-dihydro-2H-1-benzopyran-3-amine; for the treatment of cardiovascular disorders such as hypertension and chronic heart failure |
08/21/2007 | US7259266 Benzopyran compounds useful for treating inflammatory conditions |
08/21/2007 | US7259250 C-nitroso compounds and use thereof |
08/21/2007 | US7259182 Deep vein thrombosis, noninsulin dependent diabetes, atherosclerosis, and pulmonary fibrosis treatment; cardiovascular and brain disorders |
08/21/2007 | US7259166 Substituted-cycloalkyl and oxygenated-cycloalkyl glucokinase activators |
08/21/2007 | US7259157 N-substituted nonaryl-heterocyclo amidyl NMDA/NR2B Antagonists |
08/21/2007 | CA2315827C Substituted pyridine and pyridazine compounds and their pharmaceutical use |
08/21/2007 | CA2304965C ((cyclo)alkyl substituted)-gamma-aminobutyric acid derivatives (=gaba analogues), their preparation and their use in the treatment of neurological disorders |
08/21/2007 | CA2099589C Enantiomerically pure .beta.-d-(-)-dioxolane-nucleosides |
08/16/2007 | WO2007092403A1 N-phenylbenzotriazolyl c-kit inhibitors |
08/16/2007 | WO2007091950A1 Benzimidazoles and imidazopyridines useful in the treatment of diseases or disorders associated with cannabinoid receptor 2 (cb2) such as pain |
08/16/2007 | WO2007091736A1 Novel coumarin derivative having antitumor activity |
08/16/2007 | WO2007091713A1 Polynuclear complex and polymer thereof |
08/16/2007 | WO2007091570A1 Binding inhibitor of sphingosine-1-phosphate |